Clinical trial
BradyXplore Phase II: Bradykinesia Feature Extraction System
NCT02358876 is registered in ClinicalTrials.gov with Great Lakes NeuroTechnologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BradyXplore Phase II: Bradykinesia Feature Extraction System
- Lead sponsor
- Great Lakes NeuroTechnologies Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- July 31, 2015
- Enrollment
- 32 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease